Category: Latest News

Promising Path for Periprosthetic Hip Infection Recovery: The Power of Phage-Antibiotic Combination Therapy

Promising Path for Periprosthetic Hip Infection Recovery: The Power of Phage-Antibiotic Combination Therapy

Posted on by Targeting Phage Therapy
A new Russian study, published in the journal “Viruses”, study delves into the efficacy of combined phage/antibiotic therapy for treating periprosthetic joint infection (PJI) in adult patients with deep PJI of the hip joint. The research, which included 45 adult patients undergoing one-stage revision surgery, presents compelling evidence that could reshape the landscape of PJI…
Posted on December 5, 2023
Read More
Sterile Faecal Filtrate Transplantation Shows Promise in Managing Metabolic Syndrome, According to Double-Blind Clinical Trial

Sterile Faecal Filtrate Transplantation Shows Promise in Managing Metabolic Syndrome, According to Double-Blind Clinical Trial

Posted on by Targeting Phage Therapy
Overview of the faecal samples used for the bulk metagenomic sequencing (for bacteriome and phageome) and the metagenomic sequencing of the viral-like particles (VLP) A double-blind, randomised, placebo-controlled clinical trial was conducted by a team in The Netherlands in order to assess the efficacy and safety of sterile faecal filtrate transplantation in individuals with metabolic…
Posted on November 28, 2023
Read More
Therapeutically useful mycobacteriophages BPs and Muddy require trehalose polyphleates

Therapeutically useful mycobacteriophages BPs and Muddy require trehalose polyphleates

Posted on by Targeting Phage Therapy
Proposed roles of Pks, PapA3, FadD23, MmpL10 and PE in the synthesis and transport of TPPs and DAT Mycobacteriophages show promise as therapeutic agents for non-tuberculous mycobacterium infections. However, little is known about phage recognition of Mycobacterium cell surfaces or mechanisms of phage resistance. A new study, led by Graham F. Hatfull from the University of Pittsburgh…
Posted on September 1, 2023
Read More
Treating bladder infections with viruses

Treating bladder infections with viruses

Posted on by Targeting Phage Therapy
The pathogens that cause urinary tract infections are becoming increasingly resistant to antibiotics. ETH Zurich researchers have now developed a rapid test and a new therapeutic approach using bacteria-​infecting viruses known as phages. In brief ETH Zurich researchers have developed a new rapid test that uses bacteriophages – viruses that infect bacteria – to quickly…
Posted on July 26, 2023
Read More
Centenarians’ Diverse Gut Virome: Potential to Modulate Metabolism and Promote Healthy Lifespan

Centenarians’ Diverse Gut Virome: Potential to Modulate Metabolism and Promote Healthy Lifespan

Posted on by Targeting Phage Therapy
After last week’s meeting Targeting Phage Therapy 2023 where Prof. Edeas talked about the role of phages in microbiota modulation, this new paper (Nature Microbiology) highlights the richness of the virome and bacteriophages in Centenarians. Johansen et al., from Broad Institute of MIT and Harvard, presented a characterization of the centenarian gut virome using previously…
Posted on June 7, 2023
Read More
Microbiome-friendly phages join the campaign for better antimicrobials

Microbiome-friendly phages join the campaign for better antimicrobials

Posted on by Targeting Phage Therapy
Phages offer a possible solution to bacterial infections that become resistant to antimicrobial agents. Credit: Stocktrek Images, Inc./Alamy Stock Photo Biotech companies are racing to test bacteriophages — some as found in nature, others armed with CRISPR–Cas — to destroy drug-resistant bacteria selectively while keeping the microbiome intact. Bacteriophages are attracting investor support to do the…
Posted on April 26, 2023
Read More
Detection of Salmonella Typhi bacteriophages in surface waters as a scalable approach to environmental surveillance

Detection of Salmonella Typhi bacteriophages in surface waters as a scalable approach to environmental surveillance

Posted on by Targeting Phage Therapy
Environmental surveillance, using detection of Salmonella Typhi DNA, has emerged as a potentially useful tool to identify typhoid-endemic settings; however, it is relatively costly and requires molecular diagnostic capacity. Shrestha et al. sought to determine whether S. Typhi bacteriophages are abundant in water sources in a typhoid-endemic setting, using low-cost assays. They collected drinking and surface…
Posted on April 5, 2023
Read More
Environmental Bacteriophages for Typhoid Surveillance and Evaluating Vaccine Impact

Environmental Bacteriophages for Typhoid Surveillance and Evaluating Vaccine Impact

Posted on by Targeting Phage Therapy
Typhoid-conjugate vaccines (TCVs) provide an opportunity to reduce the burden of typhoid fever, caused by Salmonella Typhi, in endemic areas. As policymakers design vaccination strategies, accurate and high-resolution data on disease burden is crucial. However, traditional blood culture-based surveillance is resource-extensive, prohibiting its large-scale and sustainable implementation.  Salmonella Typhi is a water-borne pathogen, and here, Hooda et al.…
Posted on April 5, 2023
Read More
AP-PA02 Phage cocktail safely lowers P. aeruginosa load in Cystic Fibrosis trial

AP-PA02 Phage cocktail safely lowers P. aeruginosa load in Cystic Fibrosis trial

Posted on by Targeting Phage Therapy
  AP-PA02, an experimental phage therapy for people with cystic fibrosis (CF) and chronic Pseudomonas aeruginosa respiratory infections, was well tolerated and reduced the bacterial load in the lungs, according to top-line results from a Phase 1b/2a trial. High doses of AP-PA02 were associated with durable reductions in bacterial load in the SWARM-Pa study. Pharmacokinetics data, which refers to the movement of…
Posted on March 9, 2023
Read More
Compassionate Use of Phages Against Drug-Resistant Mycobacterial Disease

Compassionate Use of Phages Against Drug-Resistant Mycobacterial Disease

Posted on by Targeting Phage Therapy
“Phage” by Professor Graham Beards is licensed under CC BY-SA 3.0. Nontuberculous Mycobacterium infections, particularly Mycobacterium abscessus, are increasingly common among patients with cystic fibrosis and chronic bronchiectatic lung diseases. Treatment is challenging due to intrinsic antibiotic resistance. Bacteriophage therapy represents a potentially novel approach. Relatively few active lytic phages are available and there is great variation in phage susceptibilities among M.…
Posted on February 27, 2023
Read More